Nuevolution A/S Appoints Professor Mark C. Genovese as Advisor
News Nov 21, 2015
Nuevolution has announced that Dr. Mark Genovese has joined as Scientific Advisor. Mark brings a vast knowledge and expertise within the field of inflammatory diseases to Nuevolution as well as a profound understanding of pre-clinical and clinical research, supporting the commercial value of Nuevolution’s program pipeline.
Dr. Genovese serves as a Professor of Medicine and is Co-Chief of the Division of Immunology and Rheumatology at Stanford University Medical Center. He established a clinical research program at Stanford University that is focused on bench-to-bedside translational medicine in autoimmune diseases and has designed and participated in many trials investigating novel therapies and therapeutic strategies for the treatment of autoimmune disease and arthritis.
“We are happy to have initiated our collaboration with Mark, who is a leader in the field of clinical immunology, and that he has accepted to join our Advisory Panel, said Thomas Franch, CSO of Nuevolution. “We are certain that Mark’s expertise will help us to accelerate our immunology projects further to meet our ambitions of providing novel treatment options for inflammatory diseases”.
Neuropeptide Y Y1 Receptor Structure Solved, Offers New Opportunities for Anti-obesity Drug DiscoveryNews
Scientists solve the crystal structure of Neuropeptide Y Y1 Receptor, offering new opportunities for anti-obesity drug discovery.READ MORE
Crystal Structure of Neuropeptide 1 Receptor Solved, Providing Therapeutic Angle For Obesity TreatmentNews
An international team has uncovered the potential to beat obesity at the cellular level, characterizing for the first time a complex, little-understood receptor type that, when activated, shuts off hunger.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018